Bellicum Pharmaceuticals, Inc (BLCM): Kevin M. Slawin , Chief Technology Officer of Bellicum Pharmaceuticals, Inc sold 55,000 shares on Apr 22, 2016. The Insider selling transaction was reported by the company on Apr 26, 2016 to the Securities and ...